-
Je něco špatně v tomto záznamu ?
Correlating plasma protein profiles with symptomatology and treatment response in acute phase and early remission of major depressive disorder
P. Křenek, E. Bartečková, M. Makarová, T. Pompa, J. Fialová Kučerová, J. Kučera, A. Damborská, J. Hořínková, J. Bienertová-Vašků
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: This study aimed to explore the relationship between plasma proteome and the clinical features of Major Depressive Disorder (MDD) during treatment of acute episode. METHODS: In this longitudinal observational study, 26 patients hospitalized for moderate to severe MDD were analyzed. The study utilized Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) alongside clinical metrics, including symptomatology derived from the Montgomery-Åsberg Depression Rating Scale (MADRS). Plasma protein analysis was conducted at the onset of acute depression and 6 weeks into treatment. Analytical methods comprised of Linear Models for Microarray Data (LIMMA), Weighted Correlation Network Analysis (WGCNA), Generalized Linear Models, Random Forests, and The Database for Annotation, Visualization and Integrated Discovery (DAVID). RESULTS: Five distinct plasma protein modules were identified, correlating with specific biological processes, and uniquely associated with symptom presentation, the disorder's trajectory, and treatment response. A module rich in proteins related to adaptive immunity was correlated with the manifestation of somatic syndrome, treatment response, and inversely associated with achieving remission. A module associated with cell adhesion was linked to affective symptoms and avolition, and played a role in the initial episodes and treatment response. Another module, characterized by proteins involved in blood coagulation and lipid transport, exhibited negative correlations with a variety of MDD symptoms and was predominantly associated with the manifestation of psychotic symptoms. CONCLUSION: This research points to a complex interplay between the plasma proteome and MDD's clinical presentation, suggesting that somatic, affective, and psychotic symptoms may represent distinct endophenotypic manifestations of MDD. These insights hold potential for advancing targeted therapeutic strategies and diagnostic tools. LIMITATIONS: The study's limited sample size and its naturalistic design, encompassing diverse treatment modalities, present methodological constraints. Furthermore, the analysis focused on peripheral blood proteins, with potential implications for interpretability.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25002478
- 003
- CZ-PrNML
- 005
- 20250123101911.0
- 007
- ta
- 008
- 250117e20240917sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fpsyt.2024.1425552 $2 doi
- 035 __
- $a (PubMed)39355377
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Křenek, Pavel $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czechia
- 245 10
- $a Correlating plasma protein profiles with symptomatology and treatment response in acute phase and early remission of major depressive disorder / $c P. Křenek, E. Bartečková, M. Makarová, T. Pompa, J. Fialová Kučerová, J. Kučera, A. Damborská, J. Hořínková, J. Bienertová-Vašků
- 520 9_
- $a OBJECTIVES: This study aimed to explore the relationship between plasma proteome and the clinical features of Major Depressive Disorder (MDD) during treatment of acute episode. METHODS: In this longitudinal observational study, 26 patients hospitalized for moderate to severe MDD were analyzed. The study utilized Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) alongside clinical metrics, including symptomatology derived from the Montgomery-Åsberg Depression Rating Scale (MADRS). Plasma protein analysis was conducted at the onset of acute depression and 6 weeks into treatment. Analytical methods comprised of Linear Models for Microarray Data (LIMMA), Weighted Correlation Network Analysis (WGCNA), Generalized Linear Models, Random Forests, and The Database for Annotation, Visualization and Integrated Discovery (DAVID). RESULTS: Five distinct plasma protein modules were identified, correlating with specific biological processes, and uniquely associated with symptom presentation, the disorder's trajectory, and treatment response. A module rich in proteins related to adaptive immunity was correlated with the manifestation of somatic syndrome, treatment response, and inversely associated with achieving remission. A module associated with cell adhesion was linked to affective symptoms and avolition, and played a role in the initial episodes and treatment response. Another module, characterized by proteins involved in blood coagulation and lipid transport, exhibited negative correlations with a variety of MDD symptoms and was predominantly associated with the manifestation of psychotic symptoms. CONCLUSION: This research points to a complex interplay between the plasma proteome and MDD's clinical presentation, suggesting that somatic, affective, and psychotic symptoms may represent distinct endophenotypic manifestations of MDD. These insights hold potential for advancing targeted therapeutic strategies and diagnostic tools. LIMITATIONS: The study's limited sample size and its naturalistic design, encompassing diverse treatment modalities, present methodological constraints. Furthermore, the analysis focused on peripheral blood proteins, with potential implications for interpretability.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bartečková, Eliška $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czechia
- 700 1_
- $a Makarová, Markéta $u Department of Physical Activities and Health Sciences, Faculty of Sport Science, Masaryk University, Brno, Czechia
- 700 1_
- $a Pompa, Tomáš $u Department of Physical Activities and Health Sciences, Faculty of Sport Science, Masaryk University, Brno, Czechia
- 700 1_
- $a Fialová Kučerová, Jana $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czechia
- 700 1_
- $a Kučera, Jan $u Department of Physical Activities and Health Sciences, Faculty of Sport Science, Masaryk University, Brno, Czechia
- 700 1_
- $a Damborská, Alena $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czechia
- 700 1_
- $a Hořínková, Jana $u Department of Psychiatry, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czechia
- 700 1_
- $a Bienertová-Vašků, Julie $u Department of Physical Activities and Health Sciences, Faculty of Sport Science, Masaryk University, Brno, Czechia $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czechia
- 773 0_
- $w MED00174602 $t Frontiers in psychiatry $x 1664-0640 $g Roč. 15 (20240917), s. 1425552
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39355377 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250117 $b ABA008
- 991 __
- $a 20250123101905 $b ABA008
- 999 __
- $a ok $b bmc $g 2254595 $s 1238481
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 15 $c - $d 1425552 $e 20240917 $i 1664-0640 $m Frontiers in psychiatry $n Front Psychiatry $x MED00174602
- LZP __
- $a Pubmed-20250117